Dutasteride is a prescription medication classified under Men's Health that belongs to the 5-alpha-reductase inhibitor class. It is supplied as a 0.5 mg pill and is used primarily to treat benign prostatic hyperplasia (BPH). In Hong Kong, dutasteride is regulated by the Department of Health’s Drug Office and is available only with a physician’s prescription.
Dutasteride inhibits both type 1 and type 2 isoforms of the enzyme 5-alpha-reductase. This enzyme normally converts testosterone into the more potent androgen dihydrotestosterone (DHT). By reducing DHT levels:
Dutasteride is well absorbed after oral ingestion, reaches peak plasma concentrations within 2-3 hours, and has a long elimination half-life of roughly 5 weeks, allowing steady-state concentrations with once-daily dosing.
Dutasteride has been investigated for male-pattern hair loss. Small-scale studies and clinical guidelines in certain countries suggest it can be more effective than finasteride for this indication. However, it is not approved for hair loss in Hong Kong and should only be considered under specialist supervision.
Off-label use requires medical supervision and individualized risk assessment.
Patients should disclose all medications, supplements, and herbal products to their healthcare provider before starting dutasteride.
Dosing must be individualized by a qualified healthcare provider, especially in the presence of liver disease or concomitant CYP3A4 inhibitors.
This article provides educational information about dutasteride and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Dutasteride is not approved for treating hair loss by Hong Kong’s regulatory authorities. While some studies suggest effectiveness, its use for this purpose should only occur under specialist supervision and after a risk-benefit evaluation.
Clinical observations indicate that many men experience noticeable symptom relief within 3 to 6 months of consistent daily dosing, though full benefits may continue to accrue up to a year.
Yes. Dutasteride lowers PSA levels by roughly 50 %, so clinicians adjust PSA interpretation by doubling the measured value or using correction algorithms to avoid false-negative results.
Co-administration is common and generally well tolerated, but the combination may increase the risk of low blood pressure. Patients should be monitored for dizziness or fainting, especially during the first few weeks.
Even a single exposure can pose a risk to a developing fetus. The woman should seek immediate medical attention, and the healthcare provider may consider monitoring fetal development closely.
Yes. Food does not significantly affect the absorption of dutasteride, so it may be taken with or without meals. Consistency in timing helps maintain stable drug levels.
There are no specific food interactions documented for dutasteride. However, maintaining a balanced diet supports overall prostate health.
Both drugs inhibit 5-alpha-reductase, but dutasteride blocks both type 1 and type 2 enzymes, leading to a greater reduction in DHT. This may translate to slightly higher efficacy for BPH, but individual response varies.
Take the missed dose as soon as you remember, unless it is close to the time for your next scheduled dose. In that case, skip the missed tablet and resume your regular dosing schedule; do not double the dose.
